PDB Short entry for 1AL8 HEADER FLAVOPROTEIN 12-JUN-97 1AL8 TITLE THREE-DIMENSIONAL STRUCTURE OF GLYCOLATE OXIDASE WITH BOUND ACTIVE- TITLE 2 SITE INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOLATE OXIDASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.3.15; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: THE STRUCTURE DESCRIBED IS A COMPLEX OF GLYCOLATE COMPND 7 OXIDASE WITH FMN AND AN INHIBITOR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SPINACIA OLERACEA; SOURCE 3 ORGANISM_COMMON: SPINACH; SOURCE 4 ORGANISM_TAXID: 3562; SOURCE 5 CELL_LINE: BL21; SOURCE 6 CELLULAR_LOCATION: PEROXISOME; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) PLYSS; SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_VECTOR: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PKS20+ KEYWDS FLAVOPROTEIN, DRUG DESIGN, INHIBITOR BINDING EXPDTA X-RAY DIFFRACTION AUTHOR K.STENBERG,Y.LINDQVIST REVDAT 4 02-AUG-23 1AL8 1 REMARK REVDAT 3 13-JUL-11 1AL8 1 VERSN REVDAT 2 24-FEB-09 1AL8 1 VERSN REVDAT 1 17-SEP-97 1AL8 0 JRNL AUTH K.STENBERG,Y.LINDQVIST JRNL TITL THREE-DIMENSIONAL STRUCTURES OF GLYCOLATE OXIDASE WITH BOUND JRNL TITL 2 ACTIVE-SITE INHIBITORS. JRNL REF PROTEIN SCI. V. 6 1009 1997 JRNL REFN ISSN 0961-8368 JRNL PMID 9144771 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.STENBERG,Y.LINDQVIST REMARK 1 TITL HIGH-LEVEL EXPRESSION, PURIFICATION AND CRYSTALLIZATION OF REMARK 1 TITL 2 RECOMBINANT SPINACH GLYCOLATE OXIDASE IN ESCHERICHIA COLI REMARK 1 REF PROTEIN EXPR.PURIF. V. 8 295 1996 REMARK 1 REFN ISSN 1046-5928 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.LINDQVIST REMARK 1 TITL REFINED STRUCTURE OF SPINACH GLYCOLATE OXIDASE AT 2 A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 209 151 1989 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 21198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1661 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE : 0.2790 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 0.32 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 0.28 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.370 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.78 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.246 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : INDIVIDUAL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM11.DNA REMARK 3 PARAMETER FILE 3 : PARAM.FMN REMARK 3 PARAMETER FILE 4 : TKP.TOP REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH11.DNA REMARK 3 TOPOLOGY FILE 3 : TOPOLOGY.FMN REMARK 3 TOPOLOGY FILE 4 : TKP.PAR REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TOPOLOGY AND PARAMETER FILES FOR THE REMARK 3 TKP-INHIBITOR WERE CREATED USING THE PROGRAM XPLO2D (REF: [O/X- REMARK 3 PLOR DICTIONARIES] G.J. KLEYWEGT, DICTIONARIES FOR HETEROS, ESF/ REMARK 3 CCP4 NEWSLETTER 31,JUNE 1995, PP. 45-50). BOND LENGTHS AND REMARK 3 ANGLES ARE FROM IDEALIZED STRUCTURES. REMARK 4 REMARK 4 1AL8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170955. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : APR-96 REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21308 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 11.10 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1GOX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 50MM REMARK 280 TRIS- BUFFER, 0.25 MG/ML FMN, 4% TERTIARY BUTANOL AND 0.5 % JF REMARK 280 5969, PH 8.3. JF 5969 IS A MIXTURE OF SYMPERONIC NPE1800 (33.3G/ REMARK 280 L), TWEEN 85 (20G/L) IN CYCLOHEXANONE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 47.70000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.70000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 46.75000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 47.70000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.70000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.75000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 47.70000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 47.70000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 46.75000 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 47.70000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 47.70000 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 46.75000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 14290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 50930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 95.40000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 95.40000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 95.40000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 95.40000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 162 REMARK 465 ARG A 163 REMARK 465 ARG A 164 REMARK 465 GLU A 165 REMARK 465 ALA A 166 REMARK 465 ASP A 167 REMARK 465 GLY A 189 REMARK 465 LYS A 190 REMARK 465 MET A 191 REMARK 465 ASP A 192 REMARK 465 LYS A 193 REMARK 465 ALA A 194 REMARK 465 ASN A 195 REMARK 465 ASP A 196 REMARK 465 SER A 197 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 30 -120.36 47.62 REMARK 500 PRO A 72 24.98 -79.73 REMARK 500 TRP A 108 37.08 -85.25 REMARK 500 PHE A 177 -7.93 76.81 REMARK 500 TYR A 202 -65.48 74.11 REMARK 500 ALA A 204 -76.69 -57.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 DHP A 361 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 360 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DHP A 361 DBREF 1AL8 A 1 359 UNP P05414 GOX_SPIOL 1 359 SEQRES 1 A 359 MET GLU ILE THR ASN VAL ASN GLU TYR GLU ALA ILE ALA SEQRES 2 A 359 LYS GLN LYS LEU PRO LYS MET VAL TYR ASP TYR TYR ALA SEQRES 3 A 359 SER GLY ALA GLU ASP GLN TRP THR LEU ALA GLU ASN ARG SEQRES 4 A 359 ASN ALA PHE SER ARG ILE LEU PHE ARG PRO ARG ILE LEU SEQRES 5 A 359 ILE ASP VAL THR ASN ILE ASP MET THR THR THR ILE LEU SEQRES 6 A 359 GLY PHE LYS ILE SER MET PRO ILE MET ILE ALA PRO THR SEQRES 7 A 359 ALA MET GLN LYS MET ALA HIS PRO GLU GLY GLU TYR ALA SEQRES 8 A 359 THR ALA ARG ALA ALA SER ALA ALA GLY THR ILE MET THR SEQRES 9 A 359 LEU SER SER TRP ALA THR SER SER VAL GLU GLU VAL ALA SEQRES 10 A 359 SER THR GLY PRO GLY ILE ARG PHE PHE GLN LEU TYR VAL SEQRES 11 A 359 TYR LYS ASP ARG ASN VAL VAL ALA GLN LEU VAL ARG ARG SEQRES 12 A 359 ALA GLU ARG ALA GLY PHE LYS ALA ILE ALA LEU THR VAL SEQRES 13 A 359 ASP THR PRO ARG LEU GLY ARG ARG GLU ALA ASP ILE LYS SEQRES 14 A 359 ASN ARG PHE VAL LEU PRO PRO PHE LEU THR LEU LYS ASN SEQRES 15 A 359 PHE GLU GLY ILE ASP LEU GLY LYS MET ASP LYS ALA ASN SEQRES 16 A 359 ASP SER GLY LEU SER SER TYR VAL ALA GLY GLN ILE ASP SEQRES 17 A 359 ARG SER LEU SER TRP LYS ASP VAL ALA TRP LEU GLN THR SEQRES 18 A 359 ILE THR SER LEU PRO ILE LEU VAL LYS GLY VAL ILE THR SEQRES 19 A 359 ALA GLU ASP ALA ARG LEU ALA VAL GLN HIS GLY ALA ALA SEQRES 20 A 359 GLY ILE ILE VAL SER ASN HIS GLY ALA ARG GLN LEU ASP SEQRES 21 A 359 TYR VAL PRO ALA THR ILE MET ALA LEU GLU GLU VAL VAL SEQRES 22 A 359 LYS ALA ALA GLN GLY ARG ILE PRO VAL PHE LEU ASP GLY SEQRES 23 A 359 GLY VAL ARG ARG GLY THR ASP VAL PHE LYS ALA LEU ALA SEQRES 24 A 359 LEU GLY ALA ALA GLY VAL PHE ILE GLY ARG PRO VAL VAL SEQRES 25 A 359 PHE SER LEU ALA ALA GLU GLY GLU ALA GLY VAL LYS LYS SEQRES 26 A 359 VAL LEU GLN MET MET ARG ASP GLU PHE GLU LEU THR MET SEQRES 27 A 359 ALA LEU SER GLY CYS ARG SER LEU LYS GLU ILE SER ARG SEQRES 28 A 359 SER HIS ILE ALA ALA ASP TRP ASP HET FMN A 360 31 HET DHP A 361 18 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM DHP 3-DECYL-2,5-DIOXO-4-HYDROXY-3-PYRROLINE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 DHP C14 H23 N O3 FORMUL 4 HOH *68(H2 O) HELIX 1 1 VAL A 6 LYS A 16 5 11 HELIX 2 2 LYS A 19 ALA A 26 1 8 HELIX 3 3 TRP A 33 ARG A 44 1 12 HELIX 4 4 GLN A 81 MET A 83 5 3 HELIX 5 5 GLY A 88 ALA A 98 1 11 HELIX 6 6 VAL A 113 THR A 119 1 7 HELIX 7 7 ARG A 134 ARG A 146 1 13 HELIX 8 8 LYS A 181 PHE A 183 5 3 HELIX 9 9 ALA A 204 GLN A 206 5 3 HELIX 10 10 TRP A 213 ILE A 222 1 10 HELIX 11 11 ALA A 235 GLN A 243 1 9 HELIX 12 12 THR A 265 ALA A 276 1 12 HELIX 13 13 GLY A 291 ALA A 299 1 9 HELIX 14 14 ARG A 309 GLU A 318 1 10 HELIX 15 15 GLU A 320 SER A 341 1 22 HELIX 16 16 LEU A 346 GLU A 348 5 3 HELIX 17 17 ARG A 351 HIS A 353 5 3 SHEET 1 A 2 THR A 62 ILE A 64 0 SHEET 2 A 2 PHE A 67 ILE A 69 -1 N ILE A 69 O THR A 62 SHEET 1 B 8 ILE A 73 ILE A 75 0 SHEET 2 B 8 GLY A 304 ILE A 307 1 N VAL A 305 O MET A 74 SHEET 3 B 8 PRO A 281 ASP A 285 1 N LEU A 284 O GLY A 304 SHEET 4 B 8 GLY A 248 VAL A 251 1 N ILE A 249 O PRO A 281 SHEET 5 B 8 PRO A 226 VAL A 232 1 N VAL A 229 O GLY A 248 SHEET 6 B 8 ALA A 151 THR A 155 1 N ILE A 152 O PRO A 226 SHEET 7 B 8 ARG A 124 LEU A 128 1 N PHE A 126 O ALA A 153 SHEET 8 B 8 MET A 103 LEU A 105 1 N MET A 103 O PHE A 125 SITE 1 AC1 23 TYR A 25 ALA A 76 PRO A 77 THR A 78 SITE 2 AC1 23 ALA A 79 SER A 106 GLN A 127 TYR A 129 SITE 3 AC1 23 THR A 155 LYS A 230 SER A 252 HIS A 254 SITE 4 AC1 23 GLY A 255 ARG A 257 ASP A 285 GLY A 286 SITE 5 AC1 23 GLY A 287 ARG A 289 GLY A 308 ARG A 309 SITE 6 AC1 23 DHP A 361 HOH A 430 HOH A 432 SITE 1 AC2 9 TYR A 24 ALA A 79 TRP A 108 TYR A 129 SITE 2 AC2 9 ILE A 168 PHE A 172 HIS A 254 ARG A 257 SITE 3 AC2 9 FMN A 360 CRYST1 95.400 95.400 93.500 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010482 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010482 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010695 0.00000